Home / Growth Engines / Pharma, Biotech & MedTech
06 —Pharma, Biotech & MedTech.
Tamil Nadu combines strong hospitals, clinical research and a growing medical-device cluster around Oragadam. The challenge is turning research into products at scale, from biologics to devices to AI-enabled discovery.
Tamil Nadu at a glance
USD 12.4 bnbioeconomy, 2025
6.4%of India's bioeconomy
~2%of India's biopharma
Core value chain
From raw materials to global markets
- Research & Discovery
- Molecules / Technology
- Product Development
- Clinical / Validation
- Manufacturing (APIs, Formulations, Devices)
- Diagnostics & Medical Devices
- Healthcare Delivery
- Global Markets (Exports)
The five conversations
Five conversations, 45 minutes each
Indicative conversations, subject to change- 01From 2% to 10%Scaling Tamil Nadu's BioPharma Share
- 02Making Oragadam India's Medtech CapitalDevices, Implants and Medical Electronics
- 03Lab to MarketClosing the Commercialisation Gap (IIT-M, CMC Vellore, TICEL Biofoundry)
- 04AI-Enabled Discovery and BioServicesTamil Nadu as a CRO, Clinical Data and BioIT Hub
- 05Bioeconomy 2030 RoadmapCoimbatore, Delta Agri-Bio and Coastal Marine Biotech Clusters
Who is in the room
Pharma and biotech companies, medical-device makers, hospitals and contract research organisations, research institutions, life-science investors and regulators.
Linked Growth Engines